UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 30, 2003
STAAR SURGICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware 0-11634 95-3797439
(State or other jurisdiction) (Commission File Number) (I.R.S. Employer
of incorporation or organization) Identification No.)
1911 Walker Avenue, Monrovia, California 91016
(Address of principal executive offices) (Zip Code)
(626) 303-7902
(Registrant's telephone number, including area code)
Item 7. Financial Statements and Exhibits.
(c) Exhibits
Exhibit Number Description
-------------- -----------
99.1 Press Release dated October 30, 2003.
99.2 Transcript of presentation given by David Bailey and John Bily
at a conference call conducted by STAAR Surgical Company on
October 30, 2003.
Item 12. Results of Operations and Financial Condition.
On October 30, 2003, STAAR Surgical Company issued a press release
announcing financial results for the third fiscal quarter of 2003. A copy is
attached as Exhibit 99.1 to this report and is incorporated herein by this
reference.
On October 30, 2003, STAAR Surgical Company held an earnings conference
call to discuss the financial results for the third fiscal quarter of 2003. A
transcript of the presentation given by David Bailey and John Bily in the call
is attached to this report as Exhibit 99.2 and is incorporated herein by this
reference.
The information in this Current Report on Form 8-K, including the
exhibits, will not be treated as "filed" for the purposes of Section 18 of the
Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the
liabilities of that section. This information will not be incorporated by
reference into a filing under the Securities Act of 1933, or into another filing
under the Exchange Act, unless that filing expressly refers to specific
information in this report.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: November 5, 2003 STAAR SURGICAL COMPANY
By: /s/ John Bily
___________________
John Bily
Chief Financial Officer
-3-
Exhibit Index
EXHIBIT NUMBER DESCRIPTION
-------------- -----------
99.1 Press Release dated October 30, 2003.
99.2 Transcript of presentation given by David Bailey and John Bily
at a conference call conducted by STAAR Surgical Company on
October 30, 2003.
-4-